Back to Search
DR. JONATHAN MARSHALL GARBER D.O.
D.O.
Hospitalist Physician
NPI: 1780063875IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
82112(SC)
Education
OTHER
Class of 2015
Research & Publications (20)
BRCA1/2-associated and sporadic breast cancers: fellow travelers or not?
PMID 19174575·Cancer Prev Res (Phila)·2009
8-other
Attitudes towards collaboration and servant leadership among nurses, physicians and residents.
PMID 19517285·J Interprof Care·2009
4-observational
Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.
PMID 19545972·Patient Educ Couns·2010
8-other
Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study.
PMID 19383884·Cancer Epidemiol Biomarkers Prev·2009
4-observational
Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
PMID 19390427·Am J Surg Pathol·2009
8-other
The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.
PMID 19583480·Thyroid·2009
8-other
Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization.
PMID 19455369·J Gen Intern Med·2009
6-review
Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).
PMID 18385162·J Pediatr Psychol·2009
4-observational
Prevention of depression in at-risk adolescents: a randomized controlled trial.
PMID 19491183·JAMA·2009
4-observational
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.
PMID 19470930·J Clin Oncol·2009
6-review
American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.
PMID 19075281·J Clin Oncol·2009
6-review
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
PMID 19584272·Cancer Res·2009
4-observational
Children's Somatization Inventory: psychometric properties of the revised form (CSI-24).
PMID 18782857·J Pediatr Psychol·2009
4-observational
Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer.
PMID 19615727·Gynecol Oncol·2009
8-other
Physicians' experiences with BRCA1/2 testing in community settings.
PMID 19001322·J Clin Oncol·2008
8-other
Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations.
PMID 18718648·Gynecol Oncol·2008
8-other
VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
PMID 19047116·Clin Cancer Res·2008
3-trial
Research issues affecting preoperative systemic therapy for operable breast cancer.
PMID 18258990·J Clin Oncol·2008
6-review
Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms.
PMID 18991123·J Clin Child Adolesc Psychol·2008
4-observational
Triple-negative breast cancer: risk factors to potential targets.
PMID 19088017·Clin Cancer Res·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2100 STANTONSBURG RD
GREENVILLE, NC 27834 - Phone
- (252) 744-0750
Quick Facts
- NPI
- 1780063875
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile